SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

Syndrome coronavirus 2 (SARS-CoV-2) pandemic is causing a second outbreak significantly delaying the hope for the virus’ complete eradication. In the absence of effective vaccines, we need effective treatments with low adverse effects that can treat hospitalized patients with COVID-19 disease. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreras, C., Pascual-Miguel, B., Mestre-Durán, C., Navarro-Zapata, A., Clares-Villa, L., Martín-Cortázar, C., De Paz, R., Marcos, A., Vicario, J. L., Balas, A., García-Sánchez, F., Eguizabal, C., Solano, C., Mora-Rillo, M., Soria, B., Pérez-Martínez, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947351/
https://www.ncbi.nlm.nih.gov/pubmed/33718360
http://dx.doi.org/10.3389/fcell.2021.620730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947351/
https://www.ncbi.nlm.nih.gov/pubmed/33718360
http://dx.doi.org/10.3389/fcell.2021.620730

Ejemplares similares